We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSBC icon
1676
HSBC
HSBC
$356B
– –
-8,022
Closed -$262K
HST icon
1677
Host Hotels & Resorts
HST
$16B
– –
-16,989
Closed -$266K
HTBK
1678
DELISTED
Heritage Commerce
HTBK
– –
-15,130
Closed -$162K
HUBG icon
1679
HUB Group
HUBG
$2.92B
– –
-8,742
Closed -$310K
HYLN icon
1680
Hyliion Holdings
HYLN
$690M
– –
-66,512
Closed -$214K
IART icon
1681
Integra LifeSciences
IART
$1.34B
– –
-11,151
Closed -$602K
IBRX icon
1682
ImmunityBio
IBRX
$8.1B
– –
-84,884
Closed -$316K
ICFI icon
1683
ICF International
ICFI
$1.72B
– –
-8,189
Closed -$778K
ICHR icon
1684
Ichor Holdings
ICHR
$2.56B
– –
-18,161
Closed -$472K
IDXX icon
1685
Idexx Laboratories
IDXX
$46.2B
– –
-767
Closed -$269K
IEP icon
1686
Icahn Enterprises
IEP
$5.3B
– –
-7,669
Closed -$369K
IEX icon
1687
IDEX
IEX
$17.3B
– –
-2,847
Closed -$517K
IMAX icon
1688
IMAX
IMAX
$2.66B
– –
-12,439
Closed -$210K
INO icon
1689
Inovio Pharmaceuticals
INO
$69M
– –
-3,230
Closed -$67K
IONS icon
1690
Ionis Pharmaceuticals
IONS
$9.4B
– –
-5,475
Closed -$203K
IOT icon
1691
Samsara
IOT
$23.8B
– –
-74,905
Closed -$837K
ISRG icon
1692
Intuitive Surgical
ISRG
$134B
– –
-1,628
Closed -$327K
IT icon
1693
Gartner
IT
$11.7B
– –
-2,883
Closed -$697K
ITRM
1694
DELISTED
Iterum Therapeutics
ITRM
– –
-20,312
Closed -$61K
IVR icon
1695
Invesco Mortgage Capital
IVR
$805M
– –
-43,145
Closed -$633K
JMIA
1696
Jumia Technologies
JMIA
$767M
– –
-13,168
Closed -$80K
JNPR
1697
DELISTED
Juniper Networks
JNPR
– –
-11,808
Closed -$337K
JWN
1698
DELISTED
Nordstrom
JWN
– –
-39,734
Closed -$840K
K
1699
DELISTED
Kellanova
K
– –
-5,684
Closed -$381K
KALA icon
1700
KALA BIO
KALA
$14.5M
– –
-5
Closed -$4K
66 67
68
69 70

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.